fig1

Why nanodiamond carriers manage to overcome drug resistance in cancer

Figure 1. Fate and basic interactions of nanodiamonds after their intravenous administration. The differences between shielded vs. unshielded and small vs. large nanoparticles are shown. ND: nanodiamond

Cancer Drug Resistance
ISSN 2578-532X (Online)

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/